Regulus Therapeutics Inc (NASDAQ:RGLS)

17.49
Delayed Data
As of Apr 24
 -0.80 / -4.37%
Today’s Change
5.40
Today|||52-Week Range
25.60
+9.04%
Year-to-Date

Today’s Trading

Previous close18.29
Today’s open18.28
Day’s range17.47 - 18.41
Volume443,464
Average volume (3 months)654,316
Market cap$883.5M
Dividend yield--
Data as of 3:59pm ET, 04/24/2015

Growth & Valuation

Earnings growth (last year)-163.27%
Earnings growth (this year)+19.23%
Earnings growth (next 5 years)--
Revenue growth (last year)-60.81%
P/E ratioNM
Price/Sales92.22
Price/Book6.48

Competitors

 Today’s
change
Today’s
% change
EGRXEagle Pharmaceutical...-1.62-2.66%
OREXOrexigen Therapeutic...-0.08-1.08%
OMEROmeros Corp-0.35-1.42%
HPTXHyperion Therapeutic...-0.11-0.24%
Data as of 3:59pm ET, 04/24/2015

Financials

Next reporting dateMay 7, 2015
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$7.7M
Annual profit (last year)-$56.7M
Net profit margin-739.08%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, CFO, Director &
CAO
Kleanthis G. Xanthopoulos
Chief Scientific Officer
Neil W. Gibson
Corporate headquarters
San Diego, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers